Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
Bank of New York Mellon Corp
> HALO
Date | Name | Ticker | Shares | Change | Value | Change | Price |
06/30/2023 | HALOZYME THERAPEUTICS, INC. | HALO | 1,330,634 | -59,037 | 47,995,971,000 | -5,075,566,000 | $36,070.00 |
03/31/2023 | HALOZYME THERAPEUTICS, INC. | HALO | 1,389,671 | -48,699 | 53,071,537,000 | -28,771,717,000 | $38,190.00 |
12/31/2022 | HALOZYME THERAPEUTICS, INC. | HALO | 1,438,370 | 1,438,370 | 81,843,254,000 | 81,843,254,000 | $56,900.00 |
09/30/2022 | HALOZYME THERAPEUTICS, INC. | HALO | 0 | -1,540,276 | 0 | -67,773,000 | |
06/30/2022 | HALOZYME THERAPEUTICS, INC. | HALO | 1,540,276 | 11,963 | 67,773,000 | 6,823,000 | $44.00 |
03/31/2022 | HALOZYME THERAPEUTICS, INC. | HALO | 1,528,313 | -11,953 | 60,950,000 | -986,000 | $39.88 |
12/31/2021 | HALOZYME THERAPEUTICS, INC. | HALO | 1,540,266 | -30,259 | 61,936,000 | -1,954,000 | $40.21 |
09/30/2021 | HALOZYME THERAPEUTICS, INC. | HALO | 1,570,525 | 92,038 | 63,890,000 | -3,248,000 | $40.68 |
06/30/2021 | HALOZYME THERAPEUTICS, INC. | HALO | 1,478,487 | 6,375 | 67,138,000 | 4,265,000 | $45.41 |
03/31/2021 | HALOZYME THERAPEUTICS, INC. | HALO | 0 | -1,472,112 | 0 | -62,873,000 | |
12/31/2020 | HALOZYME THERAPEUTICS, INC. | HALO | 1,472,112 | 753,065 | 62,873,000 | 43,976,000 | $42.71 |
09/30/2020 | HALOZYME THERAPEUTICS, INC. | HALO | 719,047 | 22,839 | 18,897,000 | 232,000 | $26.28 |
06/30/2020 | HALOZYME THERAPEUTICS, INC. | HALO | 696,208 | 73,316 | 18,665,000 | 7,459,000 | $26.81 |
03/31/2020 | HALOZYME THERAPEUTICS, INC. | HALO | 622,892 | -21,809 | 11,206,000 | -224,000 | $17.99 |
12/31/2019 | HALOZYME THERAPEUTICS, INC. | HALO | 644,701 | 1,234 | 11,430,000 | 1,449,000 | $17.73 |
09/30/2019 | HALOZYME THERAPEUTICS, INC. | HALO | 643,467 | -17,437 | 9,981,000 | -1,374,000 | $15.51 |
06/30/2019 | HALOZYME THERAPEUTICS, INC. | HALO | 660,904 | 18,737 | 11,355,000 | 1,017,000 | $17.18 |
03/31/2019 | HALOZYME THERAPEUTICS, INC. | HALO | 642,167 | -19,716 | 10,338,000 | 654,000 | $16.10 |
12/31/2018 | HALOZYME THERAPEUTICS, INC. | HALO | 661,883 | -1,032,894 | 9,684,000 | -21,110,000 | $14.63 |
09/30/2018 | HALOZYME THERAPEUTICS, INC. | HALO | 1,694,777 | -11,541 | 30,794,000 | 2,008,000 | $18.17 |
06/30/2018 | HALOZYME THERAPEUTICS, INC. | HALO | 1,706,318 | -8,642 | 28,786,000 | -4,810,000 | $16.87 |
03/31/2018 | HALOZYME THERAPEUTICS, INC. | HALO | 1,714,960 | -142,154 | 33,596,000 | -4,030,000 | $19.59 |
12/31/2017 | HALOZYME THERAPEUTICS, INC. | HALO | 1,857,114 | -242,050 | 37,626,000 | 1,164,000 | $20.26 |
09/30/2017 | HALOZYME THERAPEUTICS, INC. | HALO | 2,099,164 | 237,593 | 36,462,000 | 12,596,000 | $17.37 |
06/30/2017 | HALOZYME THERAPEUTICS, INC. | HALO | 1,861,571 | 55,081 | 23,866,000 | 454,000 | $12.82 |
03/31/2017 | HALOZYME THERAPEUTICS, INC. | HALO | 1,806,490 | 387,486 | 23,412,000 | 9,392,000 | $12.96 |
12/31/2016 | HALOZYME THERAPEUTICS, INC. | HALO | 1,419,004 | -303,500 | 14,020,000 | -6,788,000 | $9.88 |
09/30/2016 | HALOZYME THERAPEUTICS, INC. | HALO | 1,722,504 | 1,722,504 | 20,808,000 | 20,808,000 | $12.08 |
06/30/2016 | HALOZYME THERAPEUTICS, INC. | HALO | 2,279,701 | 1,783,067 | 19,674,000 | 14,970,000 | $8.63 |
03/31/2016 | HALOZYME THERAPEUTICS, INC. | HALO | 496,634 | -1,292,312 | 4,704,000 | -26,299,000 | $9.47 |
12/31/2015 | HALOZYME THERAPEUTICS, INC. | HALO | 1,788,946 | 1,282,775 | 31,003,000 | 24,204,000 | $17.33 |
09/30/2015 | HALOZYME THERAPEUTICS, INC. | HALO | 506,171 | -142,281 | 6,799,000 | -7,844,000 | $13.43 |
06/30/2015 | HALOZYME THERAPEUTICS, INC. | HALO | 648,452 | 149,427 | 14,643,000 | 9,713,000 | $22.58 |
03/31/2015 | HALOZYME THERAPEUTICS, INC. | HALO | 622,210 | 75,772 | 8,884,000 | 3,611,000 | $14.28 |
12/31/2014 | HALOZYME THERAPEUTICS, INC. | HALO | 546,438 | 2,666 | 5,273,000 | 324,000 | $9.65 |
<< Prev Next >> |
|